Compare VSAT & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSAT | DVA |
|---|---|---|
| Founded | 1986 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 9.9B |
| IPO Year | 1996 | 2002 |
| Metric | VSAT | DVA |
|---|---|---|
| Price | $87.69 | $197.66 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $59.80 | ★ $156.75 |
| AVG Volume (30 Days) | ★ 1.8M | 885.6K |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.88 | N/A |
| EPS | N/A | ★ 2.87 |
| Revenue | N/A | ★ $13,643,069,000.00 |
| Revenue This Year | $5.32 | $3.85 |
| Revenue Next Year | $3.57 | $3.07 |
| P/E Ratio | ★ N/A | $68.05 |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $8.70 | $101.00 |
| 52 Week High | $87.48 | $202.69 |
| Indicator | VSAT | DVA |
|---|---|---|
| Relative Strength Index (RSI) | 73.29 | 67.88 |
| Support Level | $28.10 | $191.57 |
| Resistance Level | N/A | $202.69 |
| Average True Range (ATR) | 4.67 | 5.27 |
| MACD | 1.17 | -0.91 |
| Stochastic Oscillator | 87.72 | 55.94 |
Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.